Publications by authors named "Ian Forbes"

Claim this Profile
I
Impact of Interstitial Ni on the Thermoelectric Properties of the Half-Heusler TiNiSn.
Sonia A Barczak, Jim Buckman, Ronald I Smith, Annabelle R Baker, Eric Don, Ian Forbes

Materials (Basel)· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian suppression in a marsupial following single treatment with a gonadotrophin-releasing hormone agonist in microspheres.
Ryan Robert Witt, Ian Ross Forbes, John McBain, John Cameron Rodger

Reprod Fertil Dev· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PerCEN trial participant perspectives on the implementation and outcomes of person-centered dementia care and environments.
Lynn Chenoweth, Yun-Hee Jeon, Jane Stein-Parbury, Ian Forbes, Richard Fleming

Int Psychogeriatr· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PerCEN: a cluster randomized controlled trial of person-centered residential care and environment for people with dementia.
Lynn Chenoweth, Ian Forbes, Richard Fleming, Madeleine T King, Jane Stein-Parbury

Int Psychogeriatr· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse cope elimination of hydroxylamines and alkenes or alkynes: theoretical investigation of tether length and substituent effects.
Elizabeth H Krenske, Edwin C Davison, Ian T Forbes, Jacqueline A Warner, Adrian L Smith

J Am Chem Soc· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol of a randomised controlled group trial of client and care outcomes in the residential dementia care setting.
Lynn Chenoweth, Madeleine King, Georgina Luscombe, Ian Forbes, Yun-Hee Jeon

Worldviews Evid Based Nurs· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the Birth Unit Design Spatial Evaluation Tool (BUDSET) in Australia: a pilot study.
Maralyn J Foureur, Nicky Leap, Deborah L Davis, Ian F Forbes, Caroline E S Homer

HERD· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing the Birth Unit Design Spatial Evaluation Tool (BUDSET) in Australia: a qualitative study.
Maralyn J Foureur, Nicky Leap, Deborah L Davis, Ian F Forbes, Caroline E S Homer

HERD· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between birth unit design and safe, satisfying birth: developing a hypothetical model.
Maralyn Foureur, Deborah Davis, Jennifer Fenwick, Nicky Leap, Rick Iedema, Ian Forbes

Midwifery· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.
Dale J Johnson, Ian T Forbes, Steve P Watson, Vincenzo Garzya, Graeme I Stevenson

Bioorg Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists.
Brian Budzik, Vincenzo Garzya, Dongchuan Shi, Graham Walker, Marie Woolley-Roberts, Ian T Forbes

ACS Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.
Brian Budzik, Vincenzo Garzya, Dongchuan Shi, Graham Walker, Yann Lauchart, Ian T Forbes

Bioorg Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.
Brian Budzik, Vincenzo Garzya, Dongchuan Shi, James J Foley, Ralph A Rivero, Ian T Forbes

Bioorg Med Chem Lett· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic polypharmacy does not increase the risk for side effects.
Soma Ganesan, Ross Taylor, Kiran Rabheru, Ian Forbes, Jane Dumontet

Schizophr Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies towards the identification of a new generation of atypical antipsychotic agents.
Vincenzo Garzya, Ian T Forbes, Andrew D Gribble, Mike S Hadley, Andrew P Lightfoot

Bioorg Med Chem Lett· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.
Martyn D Wood, Claire Scott, Kirsten Clarke, Julie Westaway, Ceri H Davies, Ian T Forbes

Eur J Pharmacol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
States of uncertainty: governing the empire of biotechnology.
Ian Forbes

New Genet Soc· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist.
Christopher J Langmead, Victoria A H Fry, Ian T Forbes, Clive L Branch, Arthur Christopoulos

Mol Pharmacol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.
Theo A Berkhout, Frank E Blaney, Angela M Bridges, David G Cooper, Ian T Forbes

J Med Chem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats.
David R Thomas, Sergio Melotto, Mario Massagrande, Andrew D Gribble, Phillip Jeffrey, Ian T Forbes

Br J Pharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel series of selective 5-HT7 receptor antagonists.
Ian T Forbes, David G Cooper, Emma K Dodds, Sara E Douglas, Andrew D Gribble

Bioorg Med Chem Lett· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.
Ian T Forbes, Sara Douglas, Andrew D Gribble, Robert J Ife, Andrew P Lightfoot

Bioorg Med Chem Lett· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of increased market competition on hospital services in Shandong and Henan Provinces.
Ian Forbes, Don Hindle, Pieter Degeling, Kai Zhang, Lingzhong Xu

Aust Health Rev· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis